参考文献/References:
[1] THUY A V,REIMANN C M,HEMDAN N Y.Sp-hingosine 1-phosphate in blood:function,metabolism,and fate[J].Cell Physiol Biochem,2014,34(1):158-171.
[2] KURANO M,TSUKAMOTO K,OHKAWA R,et al.Liver involvement in sphingosine1-phosphate dynamism revealed by adenoviral hepatic overexpression of apolipoprotein M[J].Atherosclerosis,2013,229(1):102-109.
[3] SCHERER M,SCHMITZ G,LIEBISCH G.High-throughput analysis of sphingosine 1-phosphate,sphinganine 1-phosphate,and lysophosphatidic acid in plasma samples by liquid chromatography-tandem mass spectrometry[J].Clin Chem,2009,55(6):1218-1222.[4] SEVVANA M,AHNSTROM J,EGERER-SIEBER C.Serendipitous fatty acidbinding reveals the structural determinants for ligand recognition in apolipoprotein M[J].J Mol Biol,2009,393(4):920-936.
[5] ELSOE S,AHNSTROM J,CHRISTOFFERSEN C,et al.Apolipoprotein M binds oxidized phospholipids and increases the antioxidant effect of HDL[J].Atherosclerosis,2012,221(1):91-97.
[6] KARUNA R,PARK R,OTHMAN A.Plasma levels of sphingosine-1-phosphate and apolipoprotein M in patients with monogenic disorders of HDL metabolism[J].Atherosclerosis,2011,219(2):855-863.
[7] LIU Mingxia,ALLEGOOD J C,ZHU Xuewei,et al.Uncleaved ApoM signal peptide isrequired for formation of large ApoM/sphingosine 1-phosphate( S1P)-enriched HDL particles[J].J Biol Chem,2015,290(12):7861-7870.
[8] SUTTER I,PARK R,OTHMAN A.Apolipoprotein M modulates erythrocyte effluxand tubular reabsorption of sphingosine-1-phosphate[J].J Lipid Res,2014,55(8):1730-1737.
[9] POTI F,SIMONI M,NOFER J R.Atheroprotective role of high-density lipoprotein(HDL)-associated sphingosine-1-phosphate(S1P)[J].Cardiovasc Res,2014,103(3):395-404.
[10] MURPHY A J,WOOLLARD K J,HOANG A.Hi-ghdensity lipoprotein reduces the human monocyte inflammatory response[J].Arterioscler Thromb Vasc Biol,2008,28(11):2071-2077.
[11] CHRISTOFFERSEN C,OBINATA H,KUMARASWAMY S B,et al.Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M[J].Proc Natl Acad Sci USA,2011,108(23):9613-9618.
[12] LAI W Q,IRWAN A W,GOH H H.Anti-inflammatory effects of sphingosine kinase modulation in inflammatory arthritis[J].Journal of Immunology,2008,181(11):8010-8017.
[13] GU Jingang,ZHU Chengliang,CHENG Duozhi.Enchanced levels of apolipoprotein M during HBV infection feedback suppresses HBV replication[J].Lipids Health Dis,2011,10(1):154.
[14] KITANO M,HLA T,SEKIGUCHI M,et al.Sphingosine 1-phosphate/sphingosine 1-phosphate receptor 1 signaling in rheumatoid synovium:regulation of synovial proliferation and inflammatory gene ex-pression[J].Arthritis Rheum,2006,54(3):742-753.
[15] 戴晓勇,陈永珍,华玮,等.血清淀粉样蛋白A,C反应蛋白和降钙素原在脓毒性休克中的应用价值与相关性分析[J].现代检验医学杂志,2019,34(1):47-50.
DAI Xiaoyong,CHEN Yongzhen,HUA Wei,et al.Application and correlation analysis of serum amylase A,C-reactive protein and procalcitonin in septic shock[J].Journal of Modern Laboratory Medicine,2019,34(1):47-50.
[16] NOJIRI T,KURANO M,TOKUHARA Y,et al.Modulation of sphingosine-1-phosphate and apolipoprotein M levels in the plasma,liver and kidneys in streptozotocin-induced diabetic mice[J].J Diabetes Investig,2014,5(6):639-648.
[17] WINKLER M S,NIERHAUS A,HOLZMANN M.Decreased serum concentrations of sphingosine-1-phosphate in sepsis[J].Crit Care,2015,19(1):372.
[18] BEKPINAR S,YENIDUNYA G,GURDOL F.The effect of nephropa-thy on plasmasphingosine 1-phosphate concentrations in patients with type 2 diabetes[J].Clin Biochem,2015,48(18):1264-1267.
[19] 任党利,韩海燕,周鑫,等.中性粒细胞/淋巴细胞比值在区分不同病原菌引起血流感染的价值[J].现代检验医学杂志,2017,32(2):102-105.
REN Dangli,HAN Haiyan,ZHOU Xin,et al.Clinical evaluation on ratio of neutrophil-to-lymphocyte in different pathogens[J].Journal of Modern Laboratory Medicine,2017,32(2):102-105.